Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

Table 9 Results of the comparison between the NIG and IG in March 2020

	NIG	IG	t-value	p-value
Number of people	275	141
EQ-5D-5L scores mean ± SD	0.59 ± 0.30	0.69 ± 0.74	−1.72	0.087
BI scores mean ± SD	54.2 ± 33.6	50.0 ± 34.7	1.05	0.29
MMSE scores mean ± SD	14.0 ± 9.7	13.6 ± 9.4	0.30	0.77
DBD scores mean ± SD	17.3 ± 13.2	175. ± 12.5	−0.14	0.89
VI scores mean ± SD	7.2 ± 2.9	6.7 ± 3.1	1.24	0.22
Medication costs JPY/day, mean ± SD	546.2 ± 536.8	495.0 ± 483.5	0.94	0.35
Number of medications mean ± SD	7.9 ± 3.4	6.0 ± 3.2	5.27	p < 0.001*

* Statistically significant. NIG (not improvement group), those who were prescribed both in March 2019 and March 2020 were classified into this group
IG (improvement group), participants who were prescribed and administered medications cautiously in March 2019 and not prescribed in March 2020 were classified into this group

ISSN: 1471-2318